The global immunoprotein diagnostic testing market is anticipated to reach USD 10.3 billion by 2025,
according to a new report by Grand View Research, Inc. This growth can be
attributed to the rising incidence of chronic diseases.
According to American
Heart Association’s 2017 statistics, nearly 790,000 people experience heart
attack every year in the U.S. In addition, stroke is responsible for 1 in every
20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk
of cardiovascular diseases. As a result of the aforementioned factors, the
demand for immunoprotein diagnostics is expected to rise in order to facilitate
rapid diagnosis.
According to WHO, nearly
1.69 million deaths due to lung cancer were registered in 2015 throughout the
world. Hence, fast and accurate diagnosis of such chronic diseases has become
important to reduce the high mortality rate. Immunoprotein diagnostic devices
and reagents have proved to be highly effective in rapidly detecting chronic
diseases.
Technological
advancements in the field of immunoprotein diagnostics have led to introduction
of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a
fully automated chemiluminescence analyzer that facilitates complete sample
processing. It also measures and evaluates testing samples, thereby, enhancing
the efficiency and throughput of the system.
Access Research Report of Immunoprotein Diagnostic Testing
Market@: www.grandviewresearch.com/industry-analysis/immunoprotein-diagnostic-testing-industry
Further key findings from the study suggest:
· In 2016, immunoglobulin tests dominated the
market owing to their frequent usage by healthcare professionals for diagnosing
infectious or autoimmune disorders
· C-Reactive Protein (CRP) tests held a
significant market share in 2016 due to the broad product portfolio of these
assays and reagents
· Infectious disease testing held largest
market share in 2016 owing to the increasing prevalence of infectious diseases
and high applications of immunoprotein tests
· Enzyme-based immunoassays dominated the
market in 2016 due to their frequent usage and availability of large number of
products that possess this technology
· Chemiluminescence assay is anticipated to
witness highest growth over the forecast period due to its high sensitivity and
specificity
· North America dominated the market in 2016
due to rising prevalence of cancer & increase in mortality due to
cancer-related diseases and favorable healthcare reimbursement scenario in the
U.S.
· Some of the key players are Bio-Rad
Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enzo Biochem,
Inc.; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; bioMérieux SA; and
Siemens Healthcare GmbH
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the immunoprotein diagnostic testing market on the basis of test
type, application, technology, and region:
Immunoprotein Diagnostic Testing Test Type Outlook
(Revenue, USD Million, 2014 - 2025)
·
Complement System Proteins Diagnostic Tests
·
Free Light Chain Diagnostic Tests
·
Haptoglobin Diagnostic Tests
·
Immunoglobulin Diagnostic Tests
·
Prealbumin Diagnostic Tests
·
C-Reactive Protein (CRP) Diagnostic
Tests
Immunoprotein Diagnostic Testing Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Infectious Disease Testing
·
Oncology Testing
·
Endocrine Testing
·
Toxicology Testing
·
Allergy Testing
·
Autoimmune Disease Testing
Immunoprotein Diagnostic Testing Technology Outlook
(Revenue, USD Million, 2014 - 2025)
·
Radioimmunoassay
·
Enzyme-based Immunoassay
·
Chemiluminescence Assay
·
Immunofluorescence Assay
·
Immunoturbidity Assay
·
Immunoprotein Electrophoresis
Immunoprotein Diagnostic Testing Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
o
France
o
Italy
o
Spain
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
o
Saudi Arabia
Access Press Release of
Immunoprotein Diagnostic Testing Market@: www.grandviewresearch.com/press-release/global-immunoprotein-diagnostic-testing-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment